Peter J. Larson
University of Cincinnati · 38 works · 2,812 citations · h-index 16
Top works
- Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
- AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B
- Posttranslational modifications of recombinant myotube-synthesized human factor IX
- Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A
- Host-Specific Evolutionary and Transmission Dynamics Shape the Functional Diversification of Staphylococcus epidermidis in Human Skin
- Health‐related quality of life assessment in adult haemophilia patients: a systematic review and evaluation of instruments
- Enhanced γ-Carboxylation of Recombinant Factor X Using a Chimeric Construct Containing the Prothrombin Propeptide
- Development and validation of a measure of disease‐specific quality of life in young children with haemophilia
- Tissue Factor Regulates Plasminogen Binding and Activation
- Manufacturing challenges in the commercial production of recombinant coagulation factor VIII
- Structural Integrity of the γ-Carboxyglutamic Acid Domain of Human Blood Coagulation Factor IXa Is Required for Its Binding to Cofactor VIIIa
- Structure/Function Analyses of Recombinant Variants of Human Factor Xa: Factor Xa Incorporation into Prothrombinase on the Thrombin-Activated Platelet Surface Is Not Mimicked by Synthetic Phospholipid Vesicles
- Delayed hemolytic transfusion reaction due to anti-Goa, an antibody against the low-prevalence Gonzales antigen
- Modelling haemophilia epidemiology and treatment modalities to estimate the unconstrained factor VIII demand
- Associations of the skin, oral and gut microbiome with aging, frailty and infection risk reservoirs in older adults
- Intestinal Bile Acids Induce a Morphotype Switch in Vancomycin-Resistant Enterococcus that Facilitates Intestinal Colonization
- Biology of Inherited Coagulopathies: Factor IX
- Clinical impact of anti‐D in intravenous immunoglobulin
- The presurgical management with erythrocytapheresis of a patient with a high‐oxygen‐affinity, unstable Hb variant (Hb Bryn Mawr)
- Gene Therapy for Hemophilia B: Aav-Mediated Transfer of The Gene for Coagulation Factor IX to Human Muscle